Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Bixlenvo (bictegravir sodium, lenacapavir sodium)FDA approves Bixlenvo (bictegravir sodium, lenacapavir sodium)27 August 2026The FDA approved Bixlenvo (bictegravir sodium, lenacapavir sodium), a drug from Gilead Sciences Inc. Form: Tablet, Oral. Granted priority review, reserved for treatments that would be a significant improvement over what exists. Application NDA221104.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)